Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Scynexis (SCYX) over the last 13 years, with Q3 2025 value amounting to $8.5 million.

  • Scynexis' Total Current Liabilities fell 6707.1% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 6707.1%. This contributed to the annual value of $24.1 million for FY2024, which is 4781.94% up from last year.
  • As of Q3 2025, Scynexis' Total Current Liabilities stood at $8.5 million, which was down 6707.1% from $10.9 million recorded in Q2 2025.
  • In the past 5 years, Scynexis' Total Current Liabilities ranged from a high of $45.6 million in Q1 2023 and a low of $8.5 million during Q3 2025
  • Moreover, its 5-year median value for Total Current Liabilities was $16.3 million (2023), whereas its average is $18.8 million.
  • Per our database at Business Quant, Scynexis' Total Current Liabilities skyrocketed by 25344.49% in 2021 and then plummeted by 6724.93% in 2025.
  • Quarter analysis of 5 years shows Scynexis' Total Current Liabilities stood at $13.6 million in 2021, then grew by 29.39% to $17.6 million in 2022, then fell by 7.46% to $16.3 million in 2023, then skyrocketed by 47.82% to $24.1 million in 2024, then tumbled by 64.86% to $8.5 million in 2025.
  • Its Total Current Liabilities was $8.5 million in Q3 2025, compared to $10.9 million in Q2 2025 and $9.0 million in Q1 2025.